Last reviewed · How we verify

NCT05131126: DyScapLat

Influence of an Anterior Latarjet-type Abutment Operation on Scapular Dyskinesia and the Muscular Stabilization Mechanisms of the Scapula (DyScapLat)

Status unknown NA Last updated 23 November 2021
What this trial tests

NA trial testing Latarjet method in Latarjet in 50 participants. Status unknown.

Timeline
22 May 2019
Primary endpoint
26 October 2021
22 May 2023

Quick facts

Lead sponsorRamsay Générale de Santé
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeother
Enrollment50
Start date22 May 2019
Primary completion26 October 2021
Estimated completion22 May 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Ramsay Générale de Santé — full company profile →

Who can join

Adults 18 to 40, male only, with Latarjet or Scapular Dyskinesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the influence of anterior abutment surgery using the Latarjet method on the kinematics of the scapula. The sub-objectives will be to show that Latarjet-type surgery does not lead to scapular dyskinesia and modification of muscle activity compared to a control group that has not undergone an operation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Latarjet

Currently open trials in the same condition.

Other Ramsay Générale de Santé trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05131126.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing